Regulation of the dopamine transporter - Addiction Research ...

Schmitt & Reith DAT Regulation
the arachidonic acid pathway. Eur. J. Pharmacol. 315:
345–354.
72. Ingram, S.L. & S.G. Amara. 2000. Arachidonic acid
stimulates a novel cocaine-sensitive cation conductance
associated with the human dopamine transporter. J.
Neurosci. 20: 550–557.
73. Chen, N., M. Appell, J.L. Berfield & M.E. Reith. 2003.
Inhibition by arachidonic acid and other fatty acids of
dopamine uptake at the human dopamine transporter.
Eur. J. Pharmacol. 478: 89–95.
74. Reese, E.A., J.R. Bunzow, S. Arttamangkul, et
al. 2007. Trace amine-associated receptor 1 displays
species-dependent stereoselectivity for isomers
of methamphetamine, amphetamine, and parahydroxyamphetamine.
J. Pharmacol. Exp. Ther. 321:
178–186.
75. Giambalvo, C.T. 2004. Mechanisms underlying the
effects of amphetamine on particulate PKC activity.
Synapse 51: 128–139.
76. Parnas, M.L. & R.A. Vaughan. 2008. Molecular structure
and composition of dopamine transporters. In
Dopamine Transporters: Chemistry, Biology and Pharmacology.
M.L. Trudell & S. Izenwasser, Eds.: 73–95.
Wiley. Hoboken, NJ.
77. Carvelli, L., J.A. Morón, K.M. Kahlig, et al. 2002. PI3kinase
regulation of dopamine uptake. J. Neurochem.
81: 859–869.
78. Lin, Z., P.W. Zhang, X. Zhu, et al. 2003. Phosphatidylinositol
3-kinase, protein kinase C, and MEK1/2 kinase
regulation of dopamine transporters (DAT) require Nterminal
DAT phosphoacceptor sites. J. Biol. Chem. 278:
20162–20170.
79. Lute,B.J.,H.Khoshbouei,C.Saunders,et al. 2008. PI3K
signaling supports amphetamine-induced dopamine
efflux. Biochem. Biophys. Res. Commun. 372: 656–661.
80. Pearson, G., F. Robinson, T. Beers Gibson, et al. 2001.
Mitogen-activated protein (MAP) kinase pathways:
regulation and physiological functions. Endocr. Rev. 22:
153–183.
81. Morón, J.A., I. Zakharova, J.V. Ferrer, et al. 2003.
Mitogen-activated protein kinase regulates dopamine
transporter surface expression and dopamine transport
capacity. J. Neurosci. 23: 8480–8488.
82. Lu, L., E. Koya, H. Zhai, et al. 2006. Role of ERK in
cocaine addiction. Trends Neurosci. 29: 695–703.
83. Welchman, R., C. Gordon & R.J. Mayer. 2005. Ubiquitin
and ubiquitin-like proteins as multifunctional signals.
Nat. Rev. Mol. Cell Biol. 6: 599–609.
84. Hicke, L. 2001. Protein regulation by monoubiquitin.
Nat. Rev. Mol. Cell Biol. 2: 195–201.
85. Hicke, L. & H. Riezman. 1996. Ubiquitination of a
yeast plasma membrane receptor signals its ligandstimulated
endocytosis. Cell 84: 277–287.
86. Egner, R. & K. Kuchler. 1996. The yeast multidrug transporter
Pdr5 of the plasma membrane is ubiquitinated
prior to endocytosis and degradation in the vacuole.
FEBS Lett. 378: 177–181.
87. Kolling, R. & S. Losko. 1997. The linker region of the
ABC-transporter Ste6 mediates ubiquitination and fast
turnover of the protein. EMBO J. 16: 2251–2261.
88. Hicke, L. 1997. Ubiquitin-dependent internalization
and down-regulation of plasma membrane proteins.
FASEB J. 11: 1215–1226.
89. Miranda, M., C.C. Wu, T. Sorkina, et al. 2005. Enhanced
ubiquitylation and accelerated degradation of
the dopamine transporter mediated by protein kinase
C. J. Biol. Chem. 280: 35617–35624.
90. Miranda, M., K.R. Dionne, T. Sorkina & A. Sorkin.
2007. Three ubiquitin conjugation sites in the amino
terminus of the dopamine transporter mediate protein
kinase C-dependent endocytosis of the transporter.
Mol. Biol. Cell 18: 313–323.
91. Sorkina, T., M. Miranda, K.R. Dionne, et al. 2006. RNA
interference screen reveals an essential role of Nedd4–2
in dopamine transporter ubiquitination and endocytosis.
J. Neurosci. 26: 8195–8205.
92. Strait, K.A. & R. Kuczenski. 1986. Dopamine autoreceptor
regulation of the kinetic state of striatal tyrosine
hydroxylase. Mol. Pharmacol. 29: 561–569.
93. Pothos, E.N., S. Przedborski, V. Davila, et al. 1998. D2-
Like dopamine autoreceptor activation reduces quantal
size in PC12 cells. J. Neurosci. 18: 5575–5585.
94. Meiergerd, S.M., T.A. Patterson & J.O. Schenk. 1993.
D2 receptors may modulate the function of the striatal
transporter for dopamine: kinetic evidence from
studies in vitro and in vivo. J. Neurochem. 61: 764–
767.
95. Cass, W.A. & G.A. Gerhardt. 1994. Direct in vivo
evidence that D2 dopamine receptors can modulate
dopamine uptake. Neurosci. Lett. 176: 259–263.
96. Zapata, A. & T.S. Shippenberg. 2002. D(3) receptor
ligands modulate extracellular dopamine clearance in
the nucleus accumbens. J. Neurochem. 81: 1035–1042.
97. Mayfield, R.D. & N.R. Zahniser. 2001. Dopamine
D2 receptor regulation of the dopamine transporter
expressed in Xenopus laevis oocytes is voltageindependent.
Mol. Pharmacol. 59: 113–121.
98. Wu, Q., M.E. Reith, Q.D. Walker, et al. 2002. Concurrent
autoreceptor-mediated control of dopamine
release and uptake during neurotransmission: an
Ann. N.Y. Acad. Sci. 1187 (2010) 316–340 c○ 2010 New York Academy of Sciences. 337